Erin Forster, MD, MPPH

Medical University of South Carolina

Live only

1) determine if Crohn's strictures are inflammatory or fibriotic.

2) describe risk profiles for endoscopic interventions on Crohn's strictures.

3) review mechanics fo performing endoscopic stricturotomy and balloon dilation for Crohn's strictures.

 

Disclosure of Financial Interest Summary

All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months. An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.

Erin Forster, MD, MPH, speaker for this lecture is a consultant for AbbVie, Johnson & Johnson,Roche/Genentech, Lilly, Pfizer and Takeda.

Research support: the companies above, plus Sanofi.

Speaker Bureau: Abbvie and Johnson & Johnson

All of the relevant financial relationships listed for these individuals have been mitigated.  No other speakers, authors, planners or content reviewers have any relevant financial relationship to disclose.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include a discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

 

Session date: 
09/17/2026 - 12:00am EDT to 11/15/2026 - 11:59pm EST
  • 1.00 AMA PRA Category 1 Credit

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This Live activity is designated for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity. 

  • 1.00 AMA PRA Category 1 Credit™ Participation

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This Live activity is designated for a maximum of 1.00 AMA PRA Category 1 Credit™ Participation. Learners should claim only credit commensurate with the extent of their participation in the activity.

Please login or register to take this course.
Faculty List: 
Course Director(s)

Venkata Rajesh Konjeti, MD FACP DABOM

has no relevant financial relationships to disclose at this time.
Peer reviewer(s)

Venkata Rajesh Konjeti, MD FACP DABOM

has no relevant financial relationships to disclose at this time.
Planner(s)

Venkata Rajesh Konjeti, MD FACP DABOM

has no relevant financial relationships to disclose at this time.
Speaker(s)

Erin Forster, MD, MPH; Jenkins Family Endowed Chair for IBD

has a financial relationship (Other) with Abbvie;.
has a financial relationship (Other) with Johnson & Johnson;.
has a financial relationship (Other) with Pfizer;.
has a financial relationship (Other) with Takeda;.
has a financial relationship (Other) with Sanofi;.
has a financial relationship (Other) with Lilly;.
has a financial relationship (Other) with Roche/Genentech;.